GenesisCare (PRIVATE.GENESISCARE)

Overall impact
C (44)

Commentary

GenesisCare is an average overall performer. With a 'C' rating of 43.6 for overall impact (30th percentile compared to all companies), GenesisCare ranks 192nd out of 228 industry peers, behind Cerba Healthcare, Allied Physicians Group, Southern Veterinary Partners and 188 others, and ahead of Rock Dental Brands, Care Fertility, Waystar Holding Corp and 33 others. On top material causes for GenesisCare's industry (Health Care Providers & Services), GenesisCare performs well in Disease Eradication (96.1 score), Child and Maternal Health (95.3), Access to Affordable Healthcare (90.4) and 9 other causes where it received an 'A' score and performs poorly in Free, Secure Flow of Information (25.7 score), Fair Labor Practices (12.2), Reduced Use of tobacco (35.5) and 32 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.GENESISCARE
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2005
Employees
5,500
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Services
SASB industry
Health Care Delivery
Headquarters
New South Wales, Australia
Share classes
TEMP.1dd4f9bf
PRIVATE.GENESISCARE
Description
Provider of specialist care for cancer and cardiovascular disease intended to give its patients the safest life outcomes possible. The company offers services including oncology, cardiology, sleep and respiratory medicine, benign treatments and clinical trial services, empowering patients to receive the appropriate care plan for those undergoing treatment for cancer, heart disease, and sleep disorders.
Material causes
Ethos considers the following causes material for GenesisCare, based on its industry sub-industry Health Care Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.